Reduced nodal burden based on tumour subtype can help tailor axillary treatment in breast cancer patients who have undergone neoadjuvant chemotherapy

Research output: Other contribution (Published) › Other contribution

Original languageEnglish (Ireland)
Media of outputOther Item
Volume104
Publication statusPublished - 1 Apr 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-being

Cite this